LH vs THC
Labcorp Holdings Inc. and Tenet Healthcare Corp., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | LH | THC |
|---|---|---|
| Revenue | $14.0B | $21.3B |
| Net income | $876.5M | $2.4B |
| Gross margin | 28.8% | — |
| Net margin | 6.3% | 11.1% |
| Return on equity | 10.5% | 56.4% |
| Diluted EPS | $10.46 | $15.49 |
| Dividend / share | $2.88 | — |
| Payout ratio | 27.5% | — |
| Free cash flow | $1.2B | $2.5B |
| Equity | $8.6B | $4.2B |
| Net debt / equity | 0.59× | 2.42× |
| Current ratio | 1.42× | 1.76× |
| Revenue CAGR 5y | −0.0% | 3.9% |
| Profit CAGR 5y | −10.8% | 25.2% |
THC bills 1.5× the revenue of LH, and keeps more of each dollar of revenue as profit (11.1% against 6.3%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | LH | THC |
|---|---|---|
| FY2025 | $14.0B | $21.3B |
| FY2024 | $13.0B | $20.7B |
| FY2023 | $12.2B | $20.6B |
| FY2022 | $11.9B | $19.2B |
| FY2021 | $13.1B | $19.5B |
| FY2020 | $14.0B | $17.6B |
| FY2019 | $11.6B | $18.5B |
| FY2018 | $11.3B | $18.3B |
| FY2017 | $10.3B | $20.6B |
| FY2016 | $9.6B | $21.1B |
Net income by year
Bottom line
| Fiscal year | LH | THC |
|---|---|---|
| FY2025 | $876.5M | $2.4B |
| FY2024 | $746.0M | $4.1B |
| FY2023 | $418.0M | $1.3B |
| FY2022 | $1.3B | $1.0B |
| FY2021 | $2.4B | $1.5B |
| FY2020 | $1.6B | $768.0M |
| FY2019 | $823.8M | $171.0M |
| FY2018 | $883.7M | $459.0M |
| FY2017 | $1.2B | $-320.0M |
| FY2016 | $711.8M | $176.0M |
Advertisement
AdSense · Rectangle 336×280